Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Boasso

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Scientifica|January 24, 2014
Type I Interferon at the Interface of Antiviral Immunity and Immune Regulation: The Curious Case of HIV-1Adriano Boasso
Blood|November 13, 2010
HIV and DC: hate at first sightAdriano Boasso
HIV Therapy|April 14, 2020
Type I interferon in HIV treatment: from antiviral drug to therapeutic targetAdriano Boasso
Plos One|March 4, 2014
Effect of immunoglobin-like transcript 7 cross-linking on plasmacytoid dendritic cells differentiation into antigen-presenting cellsBarbara Tavano, Adriano Boasso
F1000 Medicine Reports|August 31, 2011
Alloantigen-based AIDS vaccine: revisiting a "rightfully" discarded promising strategyGene M Shearer, Adriano Boasso
Clinical Immunology (Orlando, Fla.)|October 6, 2007
Chronic innate immune activation as a cause of HIV-1 immunopathogenesisAdriano Boasso, Gene M Shearer
Current Drug Metabolism|April 14, 2007
How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulationAdriano Boasso, Gene M Shearer
Lancet (London, England)|June 10, 2008
The hunt for an HIV vaccine: time to rethink recent failuresAdriano Boasso, Gene M Shearer, Mario Clerici
AIDS (London, England)|November 7, 2015
Curing HIV/AIDS beyond hematopoietic stem cell transplantGene M Shearer, Mario Clerici, David R Graham, et al.
Lancet (London, England)|November 9, 2002
AIDS in AfricaMario Clerici, Adriano Boasso, Giuliano Rizzardini, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Scientifica|January 24, 2014
Type I Interferon at the Interface of Antiviral Immunity and Immune Regulation: The Curious Case of HIV-1Adriano Boasso
Blood|November 13, 2010
HIV and DC: hate at first sightAdriano Boasso
HIV Therapy|April 14, 2020
Type I interferon in HIV treatment: from antiviral drug to therapeutic targetAdriano Boasso
Plos One|March 4, 2014
Effect of immunoglobin-like transcript 7 cross-linking on plasmacytoid dendritic cells differentiation into antigen-presenting cellsBarbara Tavano, Adriano Boasso
F1000 Medicine Reports|August 31, 2011
Alloantigen-based AIDS vaccine: revisiting a "rightfully" discarded promising strategyGene M Shearer, Adriano Boasso
Clinical Immunology (Orlando, Fla.)|October 6, 2007
Chronic innate immune activation as a cause of HIV-1 immunopathogenesisAdriano Boasso, Gene M Shearer
Current Drug Metabolism|April 14, 2007
How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulationAdriano Boasso, Gene M Shearer
Lancet (London, England)|June 10, 2008
The hunt for an HIV vaccine: time to rethink recent failuresAdriano Boasso, Gene M Shearer, Mario Clerici
AIDS (London, England)|November 7, 2015
Curing HIV/AIDS beyond hematopoietic stem cell transplantGene M Shearer, Mario Clerici, David R Graham, et al.
Lancet (London, England)|November 9, 2002
AIDS in AfricaMario Clerici, Adriano Boasso, Giuliano Rizzardini, et al.
Pageof 5